VRDN — Viridian Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Viridian Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	128	197	425	477	718
Net Total Accounts Receivable
Net Total Receivables	—	0.451	0.102	0.102	0
Prepaid Expenses
Total Current Assets	130	200	431	486	738
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.787	2.06	2.94	3.34	3.44
Other Long Term Assets
Total Assets	131	204	435	490	742
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.7	13.6	33.3	26.6	47.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.2	16	40	48.4	70.8
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	120	188	395	442	672
Total Liabilities & Shareholders' Equity	131	204	435	490	742
Total Common Shares Outstanding
Total Preferred Shares Outstanding